应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ESLA Estrella Immunopharma
盘前交易 05-14 05:30:01 EDT
1.07
-0.01
-0.93%
最高
1.12
最低
1.01
成交量
1.25万
今开
1.12
昨收
1.08
日振幅
10.19%
总市值
3,917万
流通市值
1,134万
总股本
3,661万
成交额
1.31万
换手率
0.12%
流通股本
1,060万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Estrella Immunopharma
所属市场:
NASDAQ
上市日期:
--
主营业务:
Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司,开发CD19和CD22靶向ARTEMIS T细胞疗法,有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量,改变癌症患者的生活。为了完成这一使命,该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19,一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104,它还利用Eureka的ARTEMIS技术,不仅针对CD19,还针对CD22,一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。
发行价格:
--
{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.07,"timestamp":1715630400000,"preClose":1.08,"halted":0,"volume":12478,"delay":0,"floatShares":10597250,"shares":36610870,"eps":-0.81436,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.01,"latestTime":"05-14 05:30:01 EDT","open":1.12,"high":1.12,"low":1.01,"amount":13076.929026,"amplitude":0.101852,"askPrice":1.19,"askSize":100,"bidPrice":0.9145,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.81436,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715693400000},"adr":0,"adjPreClose":1.08,"postHourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.07,"latestTime":"19:36 EDT","volume":6,"amount":6.76,"timestamp":1715643404055},"volumeRatio":1.7813498958729748},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.eurekatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.07},{"period":"1month","weight":-0.053},{"period":"3month","weight":-0.0614},{"period":"6month","weight":-0.144},{"period":"1year","weight":-0.9018},{"period":"ytd","weight":-0.036}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司,开发CD19和CD22靶向ARTEMIS T细胞疗法,有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量,改变癌症患者的生活。为了完成这一使命,该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19,一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104,它还利用Eureka的ARTEMIS技术,不仅针对CD19,还针对CD22,一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}